Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2026
Rationale and Design of RECOVER-ENERGIZE: A Platform Clinical Trial of Interventions for Exercise Intolerance With and Without Post-exertional Malaise in Long COVIDJanna Friedly, Lucinda Bateman, Lisa G Berdan, et al.Circulation|November 21, 2007
Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trialPierluigi Tricoci, Yuliya Lokhnygina, Lisa G Berdan, et al.Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Systematic adjudication of myocardial infarction end-points in an international clinical trialKenneth W Mahaffey, Robert A Harrington, Martijn Akkerhuis, et al.Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT studyKenneth W Mahaffey, Robert A Harrington, Martijn Akkerhuis, et al.The New England Journal of Medicine|April 1, 2009
Early versus delayed, provisional eptifibatide in acute coronary syndromesRobert P Giugliano, Jennifer A White, Christoph Bode, et al.Circulation. Cardiovascular Interventions|June 1, 2012
A randomized, double-blind, active-controlled phase 2 trial to evaluate a novel selective and reversible intravenous and oral P2Y12 inhibitor elinogrel versus clopidogrel in patients undergoing nonurgent percutaneous coronary intervention: the INNOVATE-PCI trialRobert C Welsh, Sunil V Rao, Uwe Zeymer, et al.American Heart Journal|December 3, 2014
Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trialGregory G Schwartz, Laurence Bessac, Lisa G Berdan, et al.JAMA Network Open|July 23, 2021
Assessment of North American Clinical Research Site Performance During the Start-up of Large Cardiovascular Clinical TrialsAkash Goyal, Tony Schibler, Brooke Alhanti, et al.JAMA Cardiology|March 19, 2020
Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) TrialGuillaume Marquis-Gravel, Matthew T Roe, Holly R Robertson, et al.The New England Journal of Medicine|May 17, 2021
Comparative Effectiveness of Aspirin Dosing in Cardiovascular DiseaseW Schuyler Jones, Hillary Mulder, Lisa M Wruck, et al.Pageof 2